|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||24.20 - 24.65|
|52 Week Range||20.45 - 30.80|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 1, 2017 - Nov 6, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||29.88|
Hedge fund Deerfield Management was fresh off a settlement with the Securities and Exchange Commission as the fourth quarter began. As the fourth quarter played out, Deerfield got back to making investment moves in health care and biotech. Deerfield initiated positions in Walgreens Boots Alliance (WBA) and Bluebird Bio (BLUE), more than tripled its holdings in Mallinckrodt (MNK), sold a fifth of its Mylan (MYL) investment, and exited NxStage Medical (NXTM) altogether.
Categories: Yahoo FinanceGet free summary analysis NxStage Medical, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of NxStage Medical, Inc. – Rockwell Medical, Inc., Fresenius Medical Care AG & Co. KGaA Sponsored ADR, Cantel Medical Corp., C. R. Bard, Inc., Baxter International Inc., Nephros, Inc., ... Read more (Read more...)
"The more I realize how things have changed for the better, the more amazed I am," said Maria Jimenez, a former NxStage patient. "Switching from in-center to home hemodialysis with NxStage System One was life-changing for me. Soon after I started dialyzing more often at home, I noticed I felt better and had more energy. I am extremely thankful for everything home hemodialysis has given me, and I know more frequent treatments got me where I am today.
In the study, outcomes among 606 Nx2me users and contemporary matched controls were compared.1 Nx2me users comprised both patients already established on home hemodialysis with the NxStage System One and new home hemodialysis patients. A key component of the Nx2me platform is the Nx2me iPad® app, which is designed to increase patients' ease of use of home therapy by capturing treatment data and wirelessly sending it to their center after each treatment, thereby reducing the need for paper flow sheets.
The top U.S. antitrust regulator has sent a chilling message to dealmakers with his opposition to AT&T Inc buying Time Warner Inc: Companies do not have to be competitors for their merger to hurt competition, and there are no simple fixes to get such deals approved. The Department of Justice's lawsuit to block the AT&T purchase could be a negative sign for other so-called "vertical" mergers - where the companies do not compete but one supplies the other - such as pharmacy operator CVS Health Corp's plan to buy insurer Aetna Inc. Investors had thought AT&T's acquisition of Time Warner, if not a slam dunk, would be approved by the Justice Department and its antitrust division chief Makan Delrahim with relatively few asset sales or conditions.
New studies being showcased at the American Society of Nephrology Congress confirm interim results from FREEDOM study and present new data on therapy retention and graduation rates. LAWRENCE, Mass., Nov. 1, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced new findings in a series of compelling research abstracts demonstrating, and further validating, the importance of more frequent home hemodialysis.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to NxStage Medical, Inc. Here are 5 ETFs with the largest exposure to NXTM-US. Comparing the performance and risk of NxStage Medical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
LAWRENCE, Mass., Oct. 18, 2017 /PRNewswire/ -- NxStage Medical, Inc. (NXTM), a leading medical technology company focused on advancing renal care, today announced Dawn Meade as the national winner of the third annual Nurse Hero Award. The Nurse Hero Award was designed to recognize the important role home hemodialysis (HHD) nurses play in helping patients to receive access to this life-changing dialysis therapy. "NxStage congratulates Dawn and all of the other nominees on being recognized by their patients and peers for their commitment to providing extraordinary patient care," said NxStage President, Joe Turk.
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for NxStage Medical, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)
ATLANTA , Oct. 2, 2017 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced the appointment of Jeffrey ...
NEW YORK , Sept. 10, 2017 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a boutique securities firm headquartered at the Empire State Building in New York ...